Back

CFTR Gene Variant Detection in Moroccan Individuals via Nanopore Long-Read Sequencing

EL Makhzen, N.; Nater, A.; Rougier, J. S.; Bokhobza, A.; Sanz, J.; Zweier, C.; Haemmerli, A.-F.; Bruggmann, R.; Bouguenouch, L.; Lakhdar Idrissi, M.; Abriel, H.

2025-02-18 genetic and genomic medicine
10.1101/2025.02.14.25322057
Show abstract

BackgroundCystic fibrosis (CF) is an autosomal recessive disease resulting from pathogenic CF transmembrane conductance regulator (CFTR) pathogenic gene variants. While CFs frequency varies among ethnicities, its epidemiology, clinical manifestations, and mutational profiles in Africa still must be explored due to the absence of a comprehensive public health strategy there. This study postulates that complete sequencing of CFTR using Oxford Nanopore Technology (ONT)-based long-read sequencing enhances the diagnostic yield. MethodsTo amplify [~]25-kb fragments covering the whole CFTR gene (NM_000492.4), we designed 11 primer pairs, and barcoded libraries were prepared and sequenced on ONT flow cells (R10.4.1) using an Mk1C device. Variant pathogenicity was assessed by expressing the variant channel in HEK293 cells and examining expression through immuno-blotting. ResultsWith sequencing data obtained from 9 Moroccan individuals (6 probands with suspected CF diagnoses and 3 parents), we identified the following variants: c.680T>G p.Leu227Arg, c.1521_1523del p.Phe508del, c.3484C>T p.Arg1162*, c.1090T>C p.Ser364Pro, c.3233T>C p.Phe1078Ser and c.2991G>C p.Leu997Phe. The analytical pipeline we developed allowed the phasing of the variants. Sanger sequencing confirmed all these results. The previously uncharacterised CFTR variants p.Ser364Pro and p.Phe1078Ser exhibit diminished expression in HEK293 cells, substantiating their pathogenic nature, with p.Phe1078Ser responding positively to the in vitro treatment with CFTR-modulator molecules. ConclusionsThis study demonstrates the potential of long-read sequencing using ONT as an efficient means to detect CF-causing variants in African populations. Given the significant genetic heterogeneity in Africa, this technique can serve as an affordable molecular screening tool for CF, especially in areas with constrained access to genetic screening. HighlightsO_LIHere, we demonstrate the efficiency of sequencing the complete CFTR gene using Oxford Nanopore Technology, an information-rich and accurate method. C_LIO_LINot-yet-reported CFTR variants of unknown significance were identified from a small cohort of nine cystic fibrosis patients and parents from Fez, Morocco. C_LIO_LIThe biochemical characterisation of the CFTR variants p.Ser364Pro, p.Phe1078Ser, and p.Leu997Phe highlights the importance of conducting expression studies when genetic variants are identified. C_LIO_LIOur proposed approach will enhance diagnostic outcomes, particularly in populations with significant genetic diversity, such as those in Africa. C_LI

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Human Mutation
based on 14 papers
Top 0.1%
11.2%
2
Scientific Reports
based on 701 papers
Top 24%
7.6%
3
Genome Medicine
based on 56 papers
Top 2%
4.7%
4
Genes
based on 21 papers
Top 0.1%
4.5%
5
Journal of Cystic Fibrosis
based on 10 papers
Top 0.1%
4.5%
6
Nature Communications
based on 483 papers
Top 18%
4.5%
7
PLOS ONE
based on 1737 papers
Top 78%
2.9%
8
Genetics in Medicine
based on 57 papers
Top 3%
2.4%
9
The American Journal of Human Genetics
based on 77 papers
Top 4%
2.4%
10
International Journal of Molecular Sciences
based on 39 papers
Top 1.0%
2.3%
11
npj Genomic Medicine
based on 18 papers
Top 0.9%
2.3%
12
Nature
based on 58 papers
Top 4%
2.3%
50% of probability mass above
13
Nature Medicine
based on 88 papers
Top 6%
2.3%
14
Human Genetics
based on 14 papers
Top 0.4%
1.8%
15
Cell Genomics
based on 34 papers
Top 2%
1.6%
16
eLife
based on 262 papers
Top 18%
1.6%
17
Microbial Genomics
based on 24 papers
Top 1%
1.3%
18
European Respiratory Journal
based on 44 papers
Top 4%
1.3%
19
European Journal of Human Genetics
based on 25 papers
Top 2%
1.3%
20
Nature Genetics
based on 72 papers
Top 7%
1.3%
21
Human Molecular Genetics
based on 28 papers
Top 4%
1.2%
22
Human Genomics
based on 13 papers
Top 1%
1.2%
23
Frontiers in Genetics
based on 32 papers
Top 4%
1.2%
24
ERJ Open Research
based on 36 papers
Top 3%
0.8%
25
Pediatric Pulmonology
based on 14 papers
Top 2%
0.8%
26
Viruses
based on 79 papers
Top 6%
0.8%
27
BMC Genomics
based on 15 papers
Top 0.6%
0.8%
28
Med
based on 26 papers
Top 1%
0.8%
29
Journal of Virological Methods
based on 20 papers
Top 2%
0.8%
30
Bioinformatics
based on 24 papers
Top 2%
0.7%